about
Sphingosine kinase 1/sphingosine 1-phosphate signalling pathway as a potential therapeutic target of pulmonary hypertensionSphingolipid signaling in metabolic disordersNogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressureNovel role for retinol-binding protein 4 in the regulation of blood pressure.The differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion.Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphateAntihypertensive treatment differentially affects vascular sphingolipid biology in spontaneously hypertensive ratsPharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusionSphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats.Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel.Regulation of immunity by lysosphingolipids and their G protein-coupled receptorsVEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors.HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.Functional variants of the sphingosine-1-phosphate receptor 1 gene associate with asthma susceptibilitySignal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.Vascular effects of sphingolipids.HDL and endothelial protection.Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury?The vascular S1P gradient-cellular sources and biological significance.A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC).Sphingosine-1-phosphate and modulation of vascular toneSphingosine 1-phosphate activates Weibel-Palade body exocytosis.Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research.Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.Fingolimod: a review of its mode of action in the context of its efficacy and safety profile in relapsing forms of multiple sclerosis.S1P Signaling and De Novo Biosynthesis in Blood Pressure HomeostasisAntioxidant and renoprotective effects of sphingosylphosphorylcholine on contrast-induced nephropathy in rats.Follow-up of hypertension in patients with multiple sclerosisFTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase.S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.Inhibition of angiogenic properties of brain endothelial cells by platelet-derived sphingosine-1-phosphate.Identification of a pepducin acting as S1P3 receptor antagonist.Sphingosine-1-phosphate acts via rho-associated kinase and nitric oxide to regulate human placental vascular tone.Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate.Unravelling HDL-Looking beyond the Cholesterol Surface to the Quality WithinEdaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells
P2860
Q26778497-171C2975-8DEA-4C2E-920D-6D76D93AD7A8Q26992148-B7F5F889-8314-4D4B-9681-0BCBF5F0FF5BQ27315147-FB0B1FFC-8134-415B-81B1-EFC22DBFADA2Q27318848-AC273D7C-DBE3-48F9-BB22-30B3A9BC6BF1Q33613072-04DE3349-0F7C-41EA-9D0D-1E3611B664ECQ33880223-2C8EDFC1-AD13-41AB-937E-F7E114F8E9E4Q33994615-D4117411-3266-4CEA-91F2-362EB00AA149Q34110842-A3CBE6A2-DB66-4D75-A0CA-90D139DEA3B8Q34113032-75185B9D-6E3F-4ED2-AC00-109E17ECE809Q35047658-0E724D74-1E3C-45FF-BB91-59ED4F708FEBQ35048357-AC7F084C-2B06-4277-B31C-0D361ADAA074Q35661331-F9817CF5-690B-4184-A98C-15B43FF8D1D2Q35971421-82D4306D-F988-4FF2-A730-E48A12C42474Q35977376-16359AFC-6366-40AD-AB00-EEEC058D1110Q36056673-DC8DBE18-BB55-4A3C-8157-B741F30D8715Q36357787-4626F01F-DCE1-4317-8AFA-27CE99A775BBQ36390340-DE3629AE-2D4A-4D74-A736-D63548E203CFQ36434460-ACF57318-74EB-4125-9B56-85599B186A00Q36772977-ABE6C55B-4083-4A92-85FF-01333AFC0D1BQ36929420-50CD5746-BEE0-4A7C-ADBB-0BA20B7985F4Q37024277-68F84851-B84D-4015-960F-225EB2801372Q37085319-FC8632AD-7338-4E86-92C3-4BB345F89C51Q37106169-D26BCAFD-E148-4955-8694-D181F92BB93CQ37171310-C70DE7D9-10F8-4B4A-8A33-25F8FEA213CCQ37388935-0242B3C8-3DA7-450B-9D9F-D49C7C7DD8E3Q38111810-4A82BF8A-B544-4DF2-A603-BB830E935E27Q38124049-BB81DB1C-092D-47E4-BBD1-44D9CDCC3263Q38639875-B2792357-2AFD-421D-8470-F0235167096DQ38869085-FBBAE94A-05F4-4551-A613-8163050A8225Q39679016-51A597F4-5B80-4703-8503-956072AD1B38Q41115384-59230412-224C-4E5E-B452-5F04A6A90E23Q42272963-95C37065-D8FD-47C2-AC9B-F2D77BCEC102Q42510910-6E234F97-E70A-42D6-BFE6-583465D4A092Q46437347-9DDC4D38-62BD-4181-8A50-48BC390EA895Q46549922-A1A80A5D-8B16-44E9-823E-8C6CE325720EQ46703396-B87BC090-6FE6-43AB-BD9A-C7E116CFA693Q54402593-FC91AA3B-FDEE-4492-9EE3-E60A40C65E23Q57176950-CAAAE9B8-3294-4546-B72C-2EA2AFDCB6B2Q58366514-FDB42916-907A-4150-8B39-1C9AEAD899CF
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Sphingosine 1-phosphate and control of vascular tone.
@en
Sphingosine 1-phosphate and control of vascular tone.
@nl
type
label
Sphingosine 1-phosphate and control of vascular tone.
@en
Sphingosine 1-phosphate and control of vascular tone.
@nl
prefLabel
Sphingosine 1-phosphate and control of vascular tone.
@en
Sphingosine 1-phosphate and control of vascular tone.
@nl
P2093
P1476
Sphingosine 1-phosphate and control of vascular tone.
@en
P2093
Ana Paula V Dantas
Junsuke Igarashi
Thomas Michel
P304
P356
10.1152/AJPHEART.01089.2002
P577
2003-06-01T00:00:00Z